Development Of A Baseline Prognostic Cytokine Signature That Correlates With Nivolumab (Nivo) Clearance (Cl): Translational Pharmacokinetic/Pharmacodynamic (Pk/Pd) Analysis In Patients With Renal Cell Carcinoma (Rcc).
JOURNAL OF CLINICAL ONCOLOGY（2019）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要